Normal 0 false false false EN-US X-NONE HE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif; mso-bidi-language:HE;}...

Infliximab API available: - from EU cGMP certified facility  - exceptional quality  - fill-finish possibilities Please ask for more info.

Adalimumab API available: - from EU cGMP certified facility  - exceptional quality  - fill-finish possibilities Please ask for more info.

I’m a representative of Parafarm (Penza, Russia) for foreign relations. We propose unique products for osteoporosis and arthritis treatment on the basis of beekeeping product, drone brood. Some information in English you can find here: https://osteomed.su/category/english/ Some other products on the basis of beekeeping products are offered too. We have got some patents, including WO, EP, US, for our products. But information in English...

Member of Farmavita.net is offering dossier in European CTD format for Ibuprofen, 600 mg, sachets. Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions....

OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE TABLETS OF 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES finalized in December 2016. THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.

There is on-going development of  generic EU CTD Dossier of  Escitalopram, tablets. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF 5 MG, 10 MG AND 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES. THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.

Farmavita.Net members, from India,  are offering  license-out  of formulation documentation for more than two hundred (200)  pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include  clincal studies.   Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.  It is expected that buyer of...

Member of Farmavita.net is offering dossier in European CTD format for Anastrazole, 1 mg, tablets. Dossier is authorised in EU. Masrting authorisation transfer is available.  License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Anastrazole  is classified as  antineoplastic medicine,  according ATC index. Offer is valid subject to confirmation, country by country. Development of this...

Farmavita.Net member has developed technology which enables development of oral dosage forms with  controlled and site specific release of active pharmaceutical ingredients. Patent pending application.   Company is looking for following types of cooperation: - Out-licensing - Joint-venture and private equity partners - Collaborative product development - Consulting or contract research contracts Description of technology: - the...

License-out offer for 6-APA API technology                                              Member of Farmavita.net offers know-how for fermentation process for manufacture of active pharmaceutical ingredient of 6 APA. Know how is available as non-exclusive license with lump sum payment. Payment is made after yield and quality of API is confirmed in the laboratory. Guarantied process parameters are:   6-APA Intermediate 6-AMINOPENICILLANIC...

Member of Farmavita.net is offering dossier in European CTD format forZopiclone, 3,75/7,5 mg; tablets.   Dossier is registered in The Netherlands. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.     Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with...

There is on-going development of generic EU CTD Dossier of Zolmitriptan, tablets and mouth dissolving tablets, 2.5/5 mg. DCP slot confirmed. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Zolmitriptan is a...

Member of Farmavita.net is offering dossier in European CTD format for Zeledronic acid, 4 mg, lyophilized powder for injection. Dossier is under development. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Zeledronic acid is classified as an antineoplastic, according ATC index. Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out...

Member of Farmavita.net is offering dossier in European CTD format for Vinorelbine, 10 mg/ml as 10 – 50 mg solution, solution for injection. Dossier is ready, not submitted. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Vinorelbine is classified as an antineoplastic, according ATC index. Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is...

Member of Farmavita.net is offering dossier in European CTD format for Venlafaxine XR, 37,5 – 75 – 150 mg, XR capsules. Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Venlafaxine XR is classified as a nervous system medicine, according ATC index. Offer is valid subject to confirmation, country by country. Development of this...

 There is on-going development of generic EU CTD Dossier of Valsartan and Valsartan+HCTZ, tablets. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Valsartan is a nonpeptide, orally active, and specific...

UK MA's for Sale: Ibuprofen 400 mg tablets and Paracetamol 500 mg tablets UK MA's for sale Instant transfer of ownership, manufacturing site transfer allowed. Please write in at bd@pharmnertia.com

Member of Farmavita.net is offering dossier in European CTD format for Triamterene/HCTZ; 50/25 mg, tablets. Dossier is registered in The Netherlands. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Triamterene/HCTZ is classified as a cardiovascular system medicine, according ATC index. Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried...